Want to see ZEPP full AI Analyst Report?
Zepp Health (ZEPP) Stock Forecast & Price Target
ZEPP Analyst Ratings
ZEPP Stock 12 Month Forecast
Average Price Target
$43.86▲(1893.64% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Siddharth Rajeev | Fundamental Research | $53.01→$43.86 | buy | 1893.64%Upside | Reiterated | 10/06/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Siddharth Rajeev | 10/06/26 | $53.01→$43.86 | buy | 1893.64%Upside | Reiterated | Fundamental Research |
Best Analysts Covering Zepp Health
Copying Siddharth Rajeev's trades and holding each position for 3 Months would result in 27.27% of your transactions generating a profit, with an average return of +46.75% per trade.
Copying Siddharth Rajeev's trades and holding each position for 1 Year would result in 27.27% of your transactions generating a profit, with an average return of +74.25% per trade.
Copying Siddharth Rajeev's trades and holding each position for 2 Years would result in 27.27% of your transactions generating a profit, with an average return of +41.53% per trade.
ZEPP Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 1 | 1 | 1 | 1 |
In the current month, ZEPP has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ZEPP average Analyst price target in the past 3 months is 43.86.
ZEPP Financial Forecast
ZEPP Earnings Forecast
Next quarter’s earnings estimate for ZEPP is -$0.05 with a range of ― to ―. The previous quarter’s EPS was -$0.05. Its overall industry beat the EPS estimate 49.22% of the time in the past 12 months.
ZEPP Sales Forecast
Next quarter’s sales forecast for ZEPP is $63.63M with a range of ― to ―. The previous quarter’s sales results were $63.63M. Its overall industry beat sales estimates 53.85% of the time in the past 12 months.
